Clinical trial

A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia

NCT00001003 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed

Key facts

NCT number NCT00001003
Title A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia
Official title Aerosols in the Treatment of Pneumocystis Carinii Pneumonia: A Nested Study Quantitating the Delivery of Aerosolized Pentamidine for Prophylaxis of PCP in Protocols ACTG 021 and ACTG 081
Lead sponsor National Institute of Allergy and Infectious Diseases (NIAID), NIH
Status Completed
Study type Interventional
Conditions Pneumonia, Pneumocystis Carinii, HIV Infections
Intervention type Drug
Interventions Pentamidine isethionate, Zidovudine
Enrollment 20
Completion Jan 1, 1992
First posted Aug 31, 2001
Last update posted Nov 4, 2021
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies